Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies
James B Lilleker(The University of Texas at San Antonio Health Science Center), Hector Chinoy(Salford Royal NHS Foundation Trust), Jamie C. Sergeant(Manchester Academic Health Science Centre), Louise Pyndt Diederichsen(Odense University Hospital), Søren Jacobsen(University of Copenhagen), Mark Roberts(Sherwood Forest Hospitals NHS Foundation Trust), Robert G. Cooper(McMaster University), Mark Guy(Manchester Academic Health Science Centre), Axel Cosmus Pyndt Diederichsen(Odense University Hospital)
Cited by 56
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Structural Requirements for Glycolipid Antigen Recognition by CD1b-Restricted T Cells
|Science|1997|438
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355